Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Whole-Genome Sequencing Analysis of Circulating DNA in Cancer and Non-Cancer Subjects

This is a prospective, multi-center clinical study of Multi-Cancer Early Detection (MCED) testing in cancer patients and healthy volunteers. This study was designed to establish a clinical and molecular database using circulating DNA from both cancer patients and non-cancer participants, advance and validate an artificial intelligence platform capable of detecting various types of cancer at an early stage, and evaluate its performance.

NCT Number	NCT07598747
Lead Sponsor	Chang Gon Kim
Conditions	Cancer, Healthy Participants
Enrollment	6,000 participants
Start Date	2024-10-14
Primary Completion	2029-10-13 (estimated)
Study Completion	2032-10-13 (estimated)
Updated on ClinicalTrials.gov	2026-05-20